General Information

The 2021 conference theme is “Research and education for HPV elimination” and through workshops, invited lectures, and oral and poster sessions presenting the latest research results, the conference will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV prevention and control in populations that are most vulnerable to HPV disease worldwide, including those in Low and Middle Income Countries.

In line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, conference topics will include:

• the epidemiology and molecular biology of PVs;
• animal models for the study of papillomavirus disease;
• basic immunology and pathogenesis of PVs;
• therapeutic and prophylactic vaccines;
• prevention of HPV associated cancers particularly cervical cancer and other PV-associated diseases, promotion of the spread of the scientific knowledge to benefit the whole community.

Together we will harness the power of innovation from HPV research to deliver global prevention and control of HPV-related disease.

Review the conference program for more details.

June 22, 2021: Abstract Submission Deadline (click to learn more)
October 4, 2021: Early Registration Deadline (click to learn more)

To benefit from reduced registration rates, you have to be in good standing for paid membership during the Conference.

For more information, please visit https://ipvsoc.org/become-a-member/

The official language of the Conference is English.

Are you following IPVS on social media yet? Be sure to connect with us on Facebook, Twitter, Instagram,  LinkedIn, or YouTube.

Join the conversation online, and make sure to use the official conference hashtag: #IPVC2021

Learn more on the dedicated social media page.

Video recordings published on the virtual platform will be transcribed automatically using the ‘Automatic speech recognition’ (ASR) feature in the platform.

Closed captioning and/or transcription is being provided solely for the convenience of our viewers. 34th International Papillomavirus Conference , the International Papillomavirus Society and Kenes International Organizers of Congresses SA do not review for accuracy any information that appears in a closed caption or transcript. The 34th International Papillomavirus Conference, the International Papillomavirus Society and Kenes International Organizers of Congresses SA make no representations or warranties, and expressly disclaims any responsibility or liability with respect to, any errors or omissions in, or the accuracy, reliability, timeliness or completeness of, any information that appears in a closed caption or transcript.

Support from pharmaceutical partners helps make this event possible.  As such, it is important that we comply with the various codes and directives relating to the manufacturing, distribution, and marketing of pharmaceutical products. The European Union directive (2001/83/EC, article 86) provides guidelines relating to medicinal products for human use. Within these guidelines is the restriction that access to pharmaceutical product marketing activities must be limited to only those participants licensed/authorized to prescribe or supply medicinal products. All participants, with the exception of the exhibitors, are asked the following question during registration: Are you licensed/authorized to prescribe or supply prescription only medicines?

Within the virtual event platform healthcare professional authorized to prescribe prescription medicines will be recognized with a letter P (Prescriber) indicated after their names.

Kenes Group
7, rue François-Versonnex,
C.P. 6053, 1211 Geneva 6
Switzerland